UK buys another 60 million doses of Pfizer/BioNTech vaccine 30th April 2021 The UK government has secured an extra 60 million doses of Pfizer/BioNTech’s COVID-19 vaccine, in a bid to strengthen plans for the autumn COVID-19 vaccination programme. The government is planning to use the additional doses in preparation for a booster programme based on clinical need ahead of winter. The Department of Health and Social Care (DHSC) added that the extra Pfizer/BioNTech jabs will be used alongside other approved vaccines as part of the booster programme. Details of the booster programme will be published in ‘due course’ and will be informed by advice from the Joint Committee on Vaccination and Immunisation (JCVI) and the results of clinical trials in the UK testing different combinations of approved COVID-19 vaccines.